The Flow Cytometry Shared Resource (FCSR) was established at Duke in 1979 to support investigators conducting basic, translational and clinical cancer research. The FCSR operates, maintains, and upgrades instrumentation for flow cytometric analysis and cell sorting of cells prepared by investigators and brought to the FCSR. The experienced staff of four performs almost all of the cell sorting and a small percentage of cell analysis, most of which is performed by facility users after being trained. The FCSR provides four analyzers, four cell sorters and one image cytometer: these cytometers are available at all times to all DCI members. Whether staff-run or self-run, fees are charged to partially offset operating expenses; DCI members receive a 40% discount across the board. In addition to cell sorting, acquiring, analyzing, archiving, and preparing flow data for publication, the FSCR staff provides consultation, technical advice, collaboration, and maintains a library to disseminate technical information to potential users. The FCSR staff has experience in nearly all areas of flow cytometric analysis and cell sorting applications and has helped investigators develop a variety of new applications. Staff members recommend assays, help develop and troubleshoot new protocols, participate actively in data analysis, and, in general, work closely with investigators to fine tune their individual experiments. The FCSR staff works integrally with investigators at all levels of experience and expertise to solve problems and meet investigators' scientific needs. Our services offered are commensurate with other facilities in the Southeast and our rates are quite competitive. We have kept our rates low for sorting cells, collecting data for analysis, or analyzing data, while at the same time not charging for consultation, project development, or cancelled appointments. While a small year-over-year decline in usage occurred in 2012, 2012 usage was still 11% higher than in 2009. Our use patterns in the coming years may be affected by stagnation of the NIH and other funders' budgets, which affect our users' ability to develop new lines of investigation and potential new users' ability to expand their work to include flow cytometry. However, even against that unknown, we expect a steady but modest increase in usage. In the past 12 months, 91 of our 146 users were DCI members, 85 of whom had peer-reviewed funding. Our DCI-member users represent all nine DCI research programs. Our long-term objectives are to continue to strategically incorporate new technologies and instruments that become available and that are needed to meet DCI members' needs and to continue to offer high quality, cost-effective service and expertise in flow cytometry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-45
Application #
9620034
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
45
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Galaz-Montoya, Monica; Wright, Sara J; Rodriguez, Gustavo J et al. (2017) ?2-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway. J Biol Chem 292:9967-9974
Lanier, Megan L; Park, Hyeri; Mukherjee, Paramita et al. (2017) Formal Synthesis of (+)-Laurencin by Gold(I)-Catalyzed Intramolecular Dehydrative Alkoxylation. Chemistry 23:7180-7184
Shi, Qiong; Liu, Hongliang; Han, Peng et al. (2017) Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol 137:1749-1756
Woyach, Jennifer A; Ruppert, Amy S; Guinn, Daphne et al. (2017) BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. J Clin Oncol 35:1437-1443
Wang, Yanru; Freedman, Jennifer A; Liu, Hongliang et al. (2017) Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer 141:731-743
Fayanju, Oluwadamilola M; Hall, Carolyn S; Bauldry, Jessica Bowman et al. (2017) Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg 214:666-671
Leu, David; Spasojevic, Ivan; Nguyen, Huy et al. (2017) CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP5. Redox Biol 12:864-871
Sauer, Scott J; Tarpley, Michael; Shah, Imran et al. (2017) Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis 38:252-260
Pan, Yongchu; Liu, Hongliang; Wang, Yanru et al. (2017) Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep 7:44634
Yin, Jieyun; Liu, Hongliang; Liu, Zhensheng et al. (2017) Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog 56:1663-1672

Showing the most recent 10 out of 480 publications